Terminal · Institutions

Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.

CLARK ESTATES INC/NY 13F Holdings -- Portfolio & Top Positions (2026-03-31)

CLARK ESTATES INC/NY (CIK 1056466) reported $416.2M across 96 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: ECML ($77.0M, 18.50%), DIS ($19.3M, 4.63%), SOLV ($18.9M, 4.55%), UL ($17.4M, 4.17%), WMG ($16.6M, 3.99%). Source: SEC Form 13F.

RankTickerCompanyValue% PortfolioSharesAction
1ECMLEA SERIES TRUST$77.0M18.50%2.1MTrimmed
2DISDISNEY WALT CO$19.3M4.63%200,000Added
3SOLVSOLVENTUM CORP$18.9M4.55%290,000Added
4ULUNILEVER PLC$17.4M4.17%305,000Added
5WMGWARNER MUSIC GROUP CORP$16.6M3.99%650,000Added
6IQVIQVIA HLDGS INC$16.2M3.90%95,200Added
7AMRZAMRIZE LTD$16.0M3.84%285,000Trimmed
8SONYSONY GROUP CORP$14.3M3.44%691,600Added
9HLNHALEON PLC$14.0M3.37%1.4MTrimmed
10MDTMEDTRONIC PLC$13.4M3.23%155,000Hold
11BLCOBAUSCH PLUS LOMB CORP$13.1M3.15%825,000Hold
12AVNSAVANOS MED INC$11.8M2.84%845,000Trimmed
13STTKSHATTUCK LABS INC$9.5M2.28%1.5MHold
14SNNSMITH & NEPHEW PLC$7.0M1.68%220,000Trimmed
15GILDGILEAD SCIENCES INC$3.6M0.87%26,022Hold
16MOALTRIA GROUP INC$3.2M0.77%48,613Hold
17LNTHLANTHEUS HLDGS INC$3.2M0.77%42,000Hold
18ZDZIFF DAVIS INC$2.9M0.70%69,700Hold
19SNXTD SYNNEX CORPORATION$2.9M0.70%17,299Hold
20HALOHALOZYME THERAPEUTICS INC$2.9M0.70%44,868Hold
21INDIVIOR PHARMACEUTICALS INC$2.8M0.68%92,300New
22NTCTNETSCOUT SYS INC$2.8M0.68%88,912Hold
23CPRXCATALYST PHARMACEUTICALS INC$2.8M0.68%113,918Hold
24BIIBBIOGEN INC$2.8M0.67%15,300Hold
25MDPEDIATRIX MEDICAL GROUP INC$2.8M0.66%129,000Hold

Source: SEC Form 13F filings · as of 2026-03-31